Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After Administration
2016 · Molecular Therapy · 61 citations
https://doi.org/10.1038/mt.2016.142
Y
Yan Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
1.4K
Citations
21
h-index
26
i10-index
Yan Li is an academic researcher from Roswell Park Comprehensive Cancer Center. The author has contributed to research in topics: Cancer Cells and Metastasis & Extracellular vesicles in disease & Complement system in diseases. The author has an h-index of 21, co-authored 52 publications.
ORCID: 0000-0002-7058-3569Papers by this author
worksEnrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma
2018 · BMC Cancer · 59 citations
https://doi.org/10.1186/s12885-018-4683-0
Targeting CD6 for the treatment of experimental autoimmune uveitis
2018 · Journal of Autoimmunity · 36 citations
https://doi.org/10.1016/j.jaut.2018.02.004
B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells
2019 · Oncogene · 36 citations
https://doi.org/10.1038/s41388-018-0674-5
Zinc finger DHHC-type palmitoyltransferase 13-mediated S-palmitoylation of GNA13 from Sertoli cell-derived extracellular vesicles inhibits autophagy in spermatogonial stem cells
2025 · Cell Communication and Signaling · 0 citations
https://doi.org/10.1186/s12964-025-02177-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat